Notícias ZyVersa Therapeutics Inc - ZVSA | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
ZyVersa Therapeutics Inc (ZVSA)
ZyVersa Therapeutics Inc (ZVSA) Notícias

ZyVersa Therapeutics Inc (ZVSA)

1,09

0,03

( 2,83% )

Atualizado: 12:31:05

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Form S-3 - Registration statement under Securities Act of 1933

Form PRE 14A - Other preliminary proxy statements

ZyVersa Therapeutics’ CEO, Stephen C. Glover, to Attend JPM’s Healthcare Conference 2025 in San Francisco

ZyVersa Therapeutics Announces Peer-Reviewed Publication Demonstrating That Inflammasome ASC Inhibitor IC 100 Protects Against Stroke-Related Cardiovascular Injury and Dysfunction in Preclinical Trial

Life Sciences Investor Forum: Presentations Now Available for Online Viewing

Form 8-K - Current report

ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

ZyVersa Therapeutics Highlights Published Data Demonstrating the Potential of Inflammasome Inhibition to Protect Pancreatic Islet Beta Cells and Attenuate Progression from Obesity to Insulin Resistance and Type 2 Diabetes

Form 8-K - Current report

ZyVersa Therapeutics Highlights Review Article Supporting the Need for Drug Therapies to Treat the Inflammation of Obesity in Addition to Weight Loss Drugs

ZyVersa Therapeutics Highlights Published Data Demonstrating That Obesity Results in Neuroinflammation Implicated in Development of Neurodegenerative Diseases

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

ZyVersa Therapeutics

C Bond Systems (PK)

Ai Media Technologies

Intesa Sanpaolo

Kreditanstalt fur Wieder...

Vontobel Financial Produ...

Intesa Sanpaolo

Graniteshares 1x Short G...

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições